Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Venture Global heads into its November 11 earnings with a familiar tension: short sellers are quietly covering, but insiders are selling into every bounce and options traders are growing more defensive by the week.
Short interest has been grinding lower for the past month, falling 4.4% over 30 days to 8.4% of the free float, with around 40.4 million shares short. The direction of travel is clear. But 8.4% is not a trivial position, and the covering has been orderly rather than panicked. Borrow costs remain low at 0.49%, up roughly 20% on the week but still cheap in absolute terms. Availability is extremely loose at 2,655%, meaning there are roughly 26 shares available to borrow for every one already lent out. There is no squeeze pressure in this lending market. Options tell a more cautious story: the put/call ratio has climbed to 0.73, nearly 1.7 standard deviations above its 20-day average of 0.67, the most defensive posture seen since September. That is still well short of the 52-week high of 1.88, but the drift higher is consistent with investors hedging a stock that has fallen 9.5% over the past month.
The Street is broadly neutral with a constructive tilt. Multiple analysts raised targets after the August print, including Scotiabank lifting to $16 and Wells Fargo to $15. JP Morgan upgraded to Overweight back in June, setting a $17 target. Morgan Stanley carries the most bullish call on the desk at $22, a 69% premium to current levels. The mean target across the analyst community is $16.78, implying roughly 29% upside from the $13.05 close. Most of those constructive voices anchor their case on Plaquemines LNG ramping toward full export capacity and the long-run demand story, global LNG demand projected to nearly double by 2050 according to S&P Global Commodity Insights. Bears point to depressed spot LNG prices that make near-term export economics uncomfortable, rising construction costs, and a lower-contracted strategy that amplifies exposure to price swings. Factor scores add little conviction: EPS momentum ranks in the 15th to 19th percentile depending on timeframe, and the short score has drifted down from around 45.9 to 44.5 over the past two weeks, a moderate reading with no obvious pressure building. The PE of 11.2x has compressed by about 0.9x over 30 days, and EV/EBITDA at 9.2x has eased slightly.
One fact worth separating from the signal: the insider sales logged in September carry less weight than they might appear. The CFO Jonathan Thayer sold around 222,000 shares across two days at roughly $14.20 to $14.40, while General Counsel Keith Larson sold roughly 1.03 million shares across three days at $14.40 to $14.82. Both sets of trades were executed under pre-arranged 10b5-1 plans, meaning the decisions were made weeks or months earlier rather than in response to current conditions. They are compensation monetisation, not discretionary bearish bets. Over the 90 days to September 18, net insider selling totalled approximately $102 million. The aggregate is large, but the 10b5-1 framing strips most of the informational content from it.
The ownership picture is dominated by the founding entity, Venture Global Partners II, which held 78.7% of shares as of March. PIMCO, which crossed the 5% threshold and filed a 13G, has since amended that filing down to 32.4% of the reported class, a significant reduction from a prior 48.9% reading. The disclosure caveat applies: these are event-driven filings around the 5% threshold, and stakes are as last disclosed. D.E. Shaw crossed the 5% threshold in September, filing a fresh 13G with a 5.4% stake and adding roughly 15 million shares in the period. Wikipedia attention has spiked sharply, with a z-score of 4.1 against the stock's own 90-day history, a signal that retail attention is running well above recent norms without implying anything about the direction of interest.
The one prior earnings data point in this dataset is from August, when the stock fell 3.8% on the day of the print and recovered almost entirely over five days, ending the week down just 0.4%. With the next print due November 11, the question is whether the stock's 9.5% one-month decline into that date changes the risk profile versus August, when it was trading roughly 10% higher. Short scores drifting lower and covers continuing are the main dynamic to monitor before then.
See the live data behind this article on ORTEX.
Open VG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
